A therapeutic vaccine targeting human papillomavirus type 16 (HPV16) induced regression in high-grade precancerous cervical lesions, according to the results from a phase II clinical trial.
A MUM from Corwen is again raising the importance of cervical screening as she celebrates a decade of being cancer free. Ali Alcock was diagnosed with cervical cancer back in 2015 and went on to ...